Under construction – not a live service
Sign in
Not yet taking people in TaiwanPhase 2/3

Chinese herbal medicine for low blood pressure during dialysis

Tests a Chinese herbal formula in dialysis patients with low blood pressure.

Plain-language title generated from the registry record
Registry title: A Pilot Trial of Chinese Medicine for Patients With Dialytic Hypotension

Key facts

Where
Kaohsiung City, TaiwanSee the site
Phase
Phase 2/3

Where in Taiwan

  • Chang Gung Memorial Hospital in Kaohsiung branchKaohsiung City, TaiwanNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Chang Gung Memorial Hospital
Trial code
NCT07425262
Record updated
25 February 2026
Original description
To evaluate the epidemiological status of traditional Chinese Medicine (TCM) constitution in patients with dialytic hypotension, and design a clinical study based on a Zheng-based herbal formulation to evaluate the clinical efficacy and safety of TCMRead full original descriptionShow less

A Pilot Randomized Waitlist-controlled Trial of a Zheng-based Chinese Medicine Intervention for Patients With Dialytic Hypotension in Taiwan

To evaluate the epidemiological status of traditional Chinese Medicine (TCM) constitution in patients with dialytic hypotension, and design a clinical study based on a Zheng-based herbal formulation to evaluate the clinical efficacy and safety of TCM

Inclusion: Maintenance bicarbonate hemodialysis (HD) for more than 1 year, three times a week 3.5 to 4.5 h HD schedule; Have experienced more than 30% episodes of IDH (defined as a systolic BP<90 mmHg on dialysis or requirement for clinical intervention) during the exposure assessment period (months 1-3) of this study; Cognitive ability to give written informed consent.

Exclusion: Allergic history to Chinese herbal medicine; Systemic diseases such as coagulation disorders, malignancy, liver diseases and cardiovascular diseases; Mental illness; Estimated survival time < 1 year; Participate in other clinical trials.

ClinicalTrials.gov NCT07425262